Role of environmental factors in the pathogenesis of classic and African-endemic Kaposi sarcoma

Cancer Letters

Volumn 244, Issue 1, 2006, Pages 1-7

  Simonart, Thierry ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Human herpesvirus 8; Insects; Iron; Kaposi sarcoma; Soil

Indexed keywords

ARTHROPOD; CANCER INCIDENCE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EPIDEMIC; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; HUMAN HERPESVIRUS 8; INSECT; KAPOSI SARCOMA; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; STATISTICAL SIGNIFICANCE; VIRUS TRANSMISSION; VOLCANO;

ARTHROPODA; HEXAPODA; HUMAN HERPESVIRUS 8;

EID: 33749236613     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.02.005     Document Type: Review

References (72)

1. Kaaya E.E., Parravicini C., Ordonez C., Gendelman R., Berti E., Gallo R.C., and Biberfeld P. Heterogeneity of spindle cells in Kaposi sarcoma: comparison of cells in lesions and in culture. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10 (1995) 295-305
2. E. Calonje, E. Wilson-Jones, Vascular tumors, Tumors and tumors-like conditions of blood vessels and lymphatics, in: Lever's, Histopathology of the skin, Lippincot-Raven, Philadelphia, PA, 1997, pp. 889-932.
3. Simonart T., Hermans P., Schandene L., and Van Vooren J.P. Phenotypic characteristics of Kaposi sarcoma tumour cells derived from patch-, plaque- and nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature. Br. J. Dermatol. 143 (2000) 557-563
4. Babal P., and Pec J. Kaposi sarcoma-still an enigma. J. Eur. Acad. Dermatol. Venereol. 17 (2003) 377-380
5. Moore P.S., and Chang Y. Kaposi sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?. Annu. Rev. Microbiol. 57 (2003) 609-639
6. Pantanowitz L., and Dezube B.J. Advances in the pathobiology and treatment of Kaposi sarcoma. Curr. Opin. Oncol. 16 (2004) 443-449
7. Verschuren E.W., Jones N., and Evan G.I. The cell cycle and how it is steered by Kaposi sarcoma-associated herpesvirus cyclin. J. Gen. Virol. 85 (2004) 1347-1361
8. Hengge U., Ruzicka T., Tyring S.K., Stuschke M., Roggendorf M., Schwartz R.A., and Seeber S. Update on Kaposi sarcoma and other HHV8 associated disorders. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect. Dis. 2 (2002) 281-292
9. Henke-Gendo C., and Schulz T.F. Transmission and disease association of Kaposi sarcoma-associated herpesvirus: recent developments. Curr. Opin. Infect. Dis. 17 (2004) 53-57
10. Lefrere J.J., Meyohas M.C., Mariotti M., Meynard J.L., Thauvin M., and Frottier J. Detection of human herpesvirus 8 DNA sequences before the appearance of Kaposi sarcoma in human immunodeficiency virus (HIV)-positive subjects with a known date of HIV seroconversion. J. Infect. Dis. 174 (1996) 283-287
11. Noel J.C., Hermans P., Andre J., Fayt I., Simonart T., Verhest A., et al. Herpesvirus-like DNA sequences and Kaposi sarcoma. Relationship with epidemiology, clinical spectrum, and histologic features. Cancer 77 (1996) 2132-2136
12. Boschoff C., Schulz T.F., Kennedy M.M., Graham A.K., Fisher C., Thomas A., et al. Kaposi sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat. Med. 1 (1995) 1274-1278
13. Chatlynne L., and Ablashi D. Seroepidemiology of Kaposi sarcoma-associated herpesvirus (KSHV). Semin. Cancer Biol. 9 (1999) 175-185
14. Martin J.N. Diagnosis and epidemiology of human herpesvirus 8 infection. Semin. Hematol. 40 (2003) 133-142
15. Gallo R.C. The enigmas of kaposi's sarcoma. Science 282 (1998) 1837-1839
16. McGeogh D., and Davison A. The descent of human herpesvirus 8. Semin. Cancer Biol. 9 (1999) 201-209
17. Chen N., Nelson K.E., Jenkins F.J., Suriyanon V., Duerr A., Costello C., et al. Seroprevalence of human herpesvirus 8 infection in Northern Thailand. Clin. Infect. Dis. 39 (2004) 1052-1058
18. Biggar R.J., Whitby D., Marshall V., Linhares A., and Black F. Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype. J. Infect. Dis. 181 (2000) 1562-1568
19. Dedicoat M., and Newton R. Review of the distribution of Kaposi sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi sarcoma. Br. J. Cancer 88 (2003) 1-3
20. Cook-Mozaffari P., Newton R., Beral V., and Bukitt D.P. The geographical distribution of Kaposi sarcoma and of lymphomas in Africa before the AIDS epidemic. Br. J. Cancer 78 (1998) 1521-1528
21. Taylor J.F., Smith P.G., Bull D., and Pike M.C. Kaposi sarcoma in Uganda: geographic and ethnic distribution. Br. J. Cancer 26 (1973) 483-495
22. Ziegler J.L. Endemic Kaposi sarcoma in Africa and local volcanic soils. Lancet 342 (1993) 1348-1351
23. McHardy J., Williams E.H., Geser A., de-The G., Beth E., and Giraldo G. Endemic Kaposi sarcoma: incidence and risk factors in the west nile district of Uganda. Int. J. Cancer 33 (1984) 203-212
24. Grulich A.E., Beral V., and Swerdlow A.J. Kaposi sarcoma in England and Wales before the AIDS epidemic. Br. J. Cancer 66 (1992) 1135-1137
25. Hjalgrim H., Melbye M., Lecker S., Frisch M., Thomsen H.K., and Larsen S.O. Epidemiology of classic Kaposi sarcoma in Denmark between 1970 and 1992. Cancer 77 (1996) 1373-1378
26. Dictor M., and Attewell R. Epidemiology of Kaposi sarcoma prior to the acquired immunodeficiency syndrome. Int. J. Cancer 42 (1988) 346-351
27. Geddes M., Franceschi S., Barchielli A., Falcini F., Carli S., Cocconi G., et al. Kaposi sarcoma in Italy before and after the AIDS epidemic. Br. J. Cancer 69 (1994) 333-336
28. Touloumi G., Kaklamanis L., Potouridou I., Katsika-Hatziolou E., Statigos J., Mueller N., et al. The epidemiologic profile of Kaposi sarcoma in Greece prior to and during the AIDS era. Int. J. Cancer 70 (1997) 538-541
29. Hjalgrim H., Tulinius H., Dalberg J., Hardarson S., Frisch M., and Melbye M. High incidence of classical Kaposi sarcoma in Iceland and the Faroe Islands. Br. J. Cancer 77 (1998) 1190-1193
30. Cottoni F., De Marco R., and Montesu M.A. Classical Kaposi sarcoma in north-east Sardinia: an overview from 1977 to 1991. Br. J. Cancer 73 (1996) 1132-1133
31. Pollack M.S., Safai B., Myskowski P.L., Gold J.W., Pandey J., and Dupont B. Frequencies of HLA and Gm immunogenetic markers in Kaposi sarcoma. Tissue Antigens 21 (1983) 1-8
32. Melbye M., Kestens L., Biggar R.J., Schreuder G.M., and Gigase P.L. HLA studies of endemic African Kaposi sarcoma patients and matched controls: no association with HLA-DR5. Int. J. Cancer 39 (1987) 182-184
33. Mann D.L., Murray C., O'Donnell M., Blattner W.A., and Goedert J.J. HLA antigen frequencies in HIV-1-related Kaposi sarcoma. J. Acquir. Immune Defic. Syndr. 3 Suppl. 1 (1990) S51-S55
34. Strichman-Almashanu L., Weltfriend S., Gideoni O., Friedman-Birnbaum R., and Pollack S. No significant association between HLA antigens and classic Kaposi sarcoma: molecular analysis of 49 Jewish patients. J. Clin. Immunol. 15 (1995) 205-209
35. Ross R.K., Casagrande J.T., Dworsky R.L., Levine A., and Mack T. Kaposi sarcoma in Los Angeles, California. J. Natl Cancer Inst. 73 (1985) 89-94
36. Dal Maso L., Polesel J., Ascoli V., Zambon P., Budroni M., Ferretti S., et al. Classic Kaposi sarcoma in Italy, 1985-1998. Br. J. Cancer 92 (2005) 188-193
37. Geddes M., Franceschi S., Balzi D., Arniani S., Gafa L., and Zanetti R. Birthplace and classic Kaposi sarcoma in Italy. J. Natl Cancer Inst. 87 (1995) 1015-1017
38. Ascoli V., Zambon P., Manno D., Guzzinati S., Zorzi M., Arca B., et al. Variability in the incidence of classic Kaposi sarcoma in the Veneto region, Northern Italy. Tumori 89 (2003) 122-124
39. Coluzzi M., Calabro M.L., Manno D., Chieco-Bianchi L., Schulz T.F., and Ascoli V. Reduced seroprevalence of Kaposi sarcoma-associated herpesvirus (KSHV), human herpesvirus 8 (HHV8), related to suppression of Anopheles density in Italy. Med. Vet. Entomol. 17 (2003) 461-464
40. Price E.W. Podoconiosis. Non-Filarial Elephantiasis (1990), Oxford University Press, Oxford
41. Ziegler J.L., Newton R., Katongole-Mbidde E., Mbulataiye S., De Cock K., Wabinga H., et al. Risk factors of Kaposi sarcoma in HIV-positive subjects in Uganda. AIDS 11 (1997) 1619-1626
42. Ziegler J.L., Newton R., Bourboulia D., Casabonne D., Beral V., Mbidde E., et al. Risk factors for Kaposi sarcoma: a case-control study of HIV-seronegative people in Uganda. Int. J. Cancer 103 (2003) 233-240
43. Krauskopf K.B. Introduction to Geochemistry (1979), McGraw-Hill, Kogahusha Ltd, London
44. Simonart T., Van Vooren J.P., Herbauts J., and Boelaert J.R. High prevalence of Kaposi sarcoma in Iceland and the Faroe Islands. Br. J. Cancer 79 (1999) 373
45. Montella M., Franceschi S., Geddes M., Arniani S., and Cocchiarella G. Classic Kaposi sarcoma and volcanic soil in southern Italy. Lancet 347 (1996) 905
46. Ollier C. Weathering (1984), Longman Group Ltd, Essex
47. Weinberg E.D. The role of iron in cancer. Eur. J. Cancer Prev. 5 (1996) 19-36
48. Huang X. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat. Res. 533 (2003) 153-171
49. Robertson A.G., and Dick W.C. Intramuscular iron and local oncogenesis. Br. Med. J. 1 (1977) 947-949
50. Dreyfus J.R. Lungencarcinoma bei Geschwisteern nach inhalation von eisenoxydaltigem Staub in der Jugend. Zeit. Klin. Med. 130 (1936) 256-260
51. Sherson D., Svane O., and Lynge E. Cancer incidence among foundry workers in Denmark. Arch. Environ. Health. 46 (1991) 75-81
52. Hsing A.W., McLaughlin J.K., Olsen J.H., Mellemkjar L., Wacholder S., Fraumeni Jr. J.F., et al. Cancer risk following primary haemochromatosis: a population-based cohort study in Denmark. Int. J. Cancer 60 (1995) 160-162
53. Knekt P., Reuanen A., Takkunen H., Aromaa A., Heliovaara M., and Hakulinen T. Body iron stores and risk of cancer. Int. J. Cancer 56 (1994) 379-382
54. Stevens R.G., Graubard B.I., Micozzi M.S., Neriishi K., and Blumberg B.S. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int. J. Cancer 56 (1994) 364-369
55. Reichard P., and Ehrenberg A. Ribonucleotide reductase: a radical enzyme. Science 221 (1983) 514-519
56. Tokoyuni S. Iron and carcinogenesis: from Fenton reactions to target genes. Redox. Rep. 7 (2002) 189-197
57. Walker E.M., and Walker S.M. Effects of iron overload on the immune sytem. Ann. Clin. Lab. Sci. 30 (2000) 354-365
58. Boelaert J.R., Weinberg G.A., and Weinberg E.D. Altered iron metabolism in HIV infection: mechanisms, possible consequences, and proposals for management. Infect. Agents Dis. 5 (1996) 36-46
59. Simonart T., Noel J.C., Andrei G., Parent D., Van Vooren J.P., Hermans P., et al. Iron as a potential cofactor in the pathogenesis of Kaposi sarcoma. Int. J. Cancer 78 (1998) 720-726
60. Simonart T., Degraef C., Andrei G., Mosselmans R., Hermans P., Van Vooren J.P., et al. Iron chelators inhibit the growth and induce the apoptosis of Kaposi sarcoma cells and of their putative endothelial precursors. J. Invest. Dermatol. 115 (2000) 893-900
61. Dai J., Huang C., Wu J., Yang C., Frenkel K., and Huang X. Iron-induced interleukin-6 gene expression: possible mediation through the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. Toxicology 203 (2004) 199-209
62. Simonart T., Degraef C., Stordeur P., Noel J.C., Mosselmans R., Van Vooren J.P., et al. Iron induces bcl-2 expression in human dermal microvascular endothelial cells. Free Rad. Res. 34 (2001) 221-235
63. Dorak M.T., Shao W., and Lobashevsky E.S. The C282Y mutation of HFE is a risk factor for HIV-related Kaposi sarcoma. Hum. Immunol. 64 S10 (2003) S145 (abstract)
64. Simonart T., De Dobbeleer G., and Stallenberg B. Classic Kaposi sarcoma of the palm in a metallurgist: role of iron filings in its development?. Br. J. Dermatol. 148 (2003) 1061-1063
65. Lunardi-Iskandar Y., Bryant J.L., Zeman R.A., Lam V.H., Samaniego F., Besnier J.M., et al. Tumorigenesis and metastasis of neoplastic Kaposi sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375 (1995) 64-68
66. Oettle A.G. Geographical and racial differences in the frequency of Kaposi sarcoma as evidence of environmental or genetic causes. Acta Un. Int. Cancer 18 (1962) 330-363
67. Gordeuk V.R., Boyd R.D., and Brittenham G.M. Dietary iron overload persists in rural sub-Saharan Africa. Lancet 1 (1986) 1310-1313
68. Haverkos H.W., Kopstein A.N., Wilson H., and Drotman P. Nitrite inhalants: history, epidemiology, and possible links to AIDS. Environ. Health Perspect. 102 (1994) 858-861
69. Haverkos H.W. Viruses, chemicals and co-carcinogenesis. Oncogene 23 (2004) 6492-6499
70. Goedert J.J., Vitale F., Lauria C., Serraino D., Tamburini M., Montella M., et al. Classical kaposi's sarcoma working group, risk factors for classical Kaposi sarcoma. J. Natl Cancer Inst. 94 (2002) 1712-1718
71. Nawar E., Mbulaiteye S.M., Gallant J.E., Wohl D.A., Ardini M., Hendersb T., et al. Risk factors for Kaposi sarcoma among HHV-8 seropositive homosexual men with AIDS. Int. J. Cancer 115 (2005) 296-300
72. Ford P.W., Hamden K.E., Whitman A.G., Bryan B.A., Chintalgattu V., McCubrey J.A., et al. Cigarette smoke concentrate inhibits Kaposi sarcoma-associated herpesvirus infection. Virus Res. 114 (2005) 172-176